Viz.ai's Recruit technology is being integrated into Amavita Heart and Vascular Health's outpatient ambulatory centers to screen and recruit patients in a clinical study on heart failure.
For its part, Viz.ai's Viz Recruit platform will aid in patient identification and patient recruitment for clinical research. The company said this will help save time for qualifying patients to receive novel therapies sooner. Viz Recruit integrates with healthcare IT systems of record to simplify the screening process, as well as identifies eligible clinical trial candidates and connects the research team to accelerate clinical trial enrollment.
Viz.ai said its part in this integration will help with access to early treatment and potentially helping to reduce overall costs for heart failure.